Literature DB >> 29268538

GARD, a new way to battle with chronic respiratory diseases, from disease oriented programmes to global partnership.

Nikolai Khaltaev1.   

Abstract

Initiated by World Health Organization (WHO) Global Chronic Respiratory Disease (CRD)-oriented programmes, Global Initiative on Asthma (GINA), GOLD-Global Initiative for Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis and its Impact on Asthma (ARIA), and Practical Approach to Lung Health (PAL) have catalyzed creation of the Global Alliance Against CRD (GARD). Forty-five countries sharing GARD's goal to reduce the burden of CRD joint GARD. In 20 countries with reliable death estimates, CRD mortality has been analyzed in 2000, 2005, 2010 and 2015. Dramatic decline in CRD mortality is seen in Kyrgyzstan, Netherlands, Italy and Republic of Korea (69%, 55%, 48%, and 48%). Positive trend in COPD mortality is seen for Lithuania (36% decline) and Spain (21%). In France, Japan, Mexico, Romania and Costa Rica, positive trend for asthma mortality is obvious from 2000 to 2015 from about 40% in France and Romania, 50% and Mexico and Czech Republic, 65% in Japan and 69% in Belgium. In Costa Rica zero asthma mortality was registered in 2015. In Czechia and Belgium decline is seen from 2000 to 2005, which then stabilized in Czech Republic and went further down in Belgium. In Finland initially, low asthma mortality remains practically unchanged with slight decline in 2015. In other countries analyzed, we did not see any positive trend in CRD mortality. In all countries with positive CRD dynamic WHO introduced activities remained active, they have been taken into local guidelines and practice and supported national authorities in implementing these evidence-based guidelines. Before GARD launch WHO initiated activities produced a good basis for further GARD movement and by 2010 we see a visible positive trend in CRD mortality in success countries. By 2015 when WHO noncommunicable disease (NCD) Global Action Plan 2013-2020 rollouts globally dramatic decline in total CRD mortality and particularly in Asthma and COPD mortality became obvious. Global disease oriented programmes, national and international partnerships combined with the Global NCD Action Plan most probable produce a positive synergistic effect on the mortality from CRD.

Entities:  

Keywords:  Asthma; Global Alliance Against Chronic Respiratory Disease (GARD); World Health Organization (WHO); allergy; chronic obstructive pulmonary disease (COPD)

Year:  2017        PMID: 29268538      PMCID: PMC5720981          DOI: 10.21037/jtd.2017.11.91

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  10 in total

Review 1.  Allergic rhinitis and its impact on asthma.

Authors:  J Bousquet; P Van Cauwenberge; N Khaltaev
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

2.  Community-based noncommunicable disease interventions: lessons from developed countries for developing ones.

Authors:  A Nissinen; X Berrios; P Puska
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

3.  A 10 year asthma programme in Finland: major change for the better.

Authors:  T Haahtela; L E Tuomisto; A Pietinalho; T Klaukka; M Erhola; M Kaila; M M Nieminen; E Kontula; L A Laitinen
Journal:  Thorax       Date:  2006-08       Impact factor: 9.139

4.  Rhinitis and onset of asthma: a longitudinal population-based study.

Authors:  Rafea Shaaban; Mahmoud Zureik; David Soussan; Catherine Neukirch; Joachim Heinrich; Jordi Sunyer; Matthias Wjst; Isa Cerveri; Isabelle Pin; Jean Bousquet; Deborah Jarvis; Peter G Burney; Françoise Neukirch; Bénédicte Leynaert
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

5.  The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality.

Authors:  Vuokko L Kinnula; Tuula Vasankari; Eva Kontula; Anssi Sovijarvi; Olli Saynajakangas; Anne Pietinalho
Journal:  Prim Care Respir J       Date:  2011-06

6.  Epidemiology of chronic airways disease.

Authors:  A J Woolcock
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

Review 7.  Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities.

Authors:  Giovanna Laurendi; Sonia Mele; Stefano Centanni; Claudio F Donner; Franco Falcone; Sandra Frateiacci; Marta Lazzeri; Antonino Mangiacavallo; Luciana Indinnimeo; Giovanni Viegi; Paola Pisanti; Giuseppe Filippetti
Journal:  Respir Med       Date:  2011-10-22       Impact factor: 3.415

Review 8.  Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.

Authors:  A A Cruz; T Popov; R Pawankar; I Annesi-Maesano; W Fokkens; J Kemp; K Ohta; D Price; J Bousquet
Journal:  Allergy       Date:  2007       Impact factor: 13.146

Review 9.  Finnish Allergy Programme 2008-2018--time to act and change the course.

Authors:  T Haahtela; L von Hertzen; M Mäkelä; M Hannuksela
Journal:  Allergy       Date:  2008-06       Impact factor: 13.146

10.  The Global Alliance against Respiratory Diseases (GARD) Country Report.

Authors:  Arzu Yorgancioglu; Alvaro A Cruz; Jean Bousquet; Nikolai Khaltaev; Shanti Mendis; Alexander Chuchalin; Eric D Bateman; Paulo Camargos; Niels H Chavannes; Chunxue Bai; Diana Deleanu; Vitezslav Kolek; Piotr Kuna; Giovanna Laurendi; Mohammed Reza Masjedi; Sonia Mele; Florin Mihaltan; José Rosado Pinto; Boleslaw Samolinski; Giselda Scalera; Talant Sooronbaev; Mohamed Awad Tageldin; Le Thi Tuyetlan; Osman Yusuf; Cezmi Akdis; Abay Baigenzhin; Carlos Baena Cagnani; Monica Fletcher; Bilun Gemicioglu; Yousser Muhammed; Hironori Sagra; Teresa To; Antje-H Fink Wagner
Journal:  Prim Care Respir J       Date:  2014-03
  10 in total
  10 in total

1.  Global Alliance against Chronic Respiratory Diseases (GARD) Brazil success case: overcoming barriers.

Authors:  Alvaro A Cruz; Paulo A Camargos; Marilyn Urrutia-Pereira; Rafael Stelmach
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Improving the quality of hospital care provided for asthma out-patients in a country in turmoil: a report from Syria.

Authors:  Yousser Mohammad; Rafea Shaaban; Hiba Alwan Salman; Boushra Nazer Shabraq; Basim Dubaybo
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 3.  Integrating primary care of chronic respiratory disease, cardiovascular disease and diabetes in Brazil: Practical Approach to Care Kit (PACK Brazil): study protocol for randomised controlled trials.

Authors:  Max O Bachmann; Eric D Bateman; Rafael Stelmach; Álvaro A Cruz; Matheus Pacheco de Andrade; Ronaldo Zonta; Jorge Zepeda; Sonia Natal; Ruth Cornick; Camilla Wattrus; Lauren Anderson; Carl Lombard; Lara R Fairall
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  The nationwide program of allergic disease prevention as an implementation of GARD guidelines in Poland.

Authors:  Filip Raciborski; Bolesław Samoliński; Edyta Krzych-Fałta; Aleksandra Grąbczewska; Filip Furman; Michał Bieszczad; Paweł Morkisz; Patrycja Witkowska; Jean Bousquet; Mariusz Gujski
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals.

Authors:  Teresa To; Giovanni Viegi; Alvaro Cruz; Luis Taborda-Barata; Innes Asher; Digambar Behera; Kazi Bennoor; Louis-Philippe Boulet; Jean Bousquet; Paulo Camargos; Claudia Conceiçao; Sandra Gonzalez Diaz; Asma El-Sony; Marina Erhola; Mina Gaga; David Halpin; Letitia Harding; Tamaz Maghlakelidze; Mohammad Reza Masjedi; Yousser Mohammad; Elizabete Nunes; Bernard Pigearias; Talant Sooronbaev; Rafael Stelmach; Ioanna Tsiligianni; Le Thi Tuyet Lan; Arunas Valiulis; Chen Wang; Sian Williams; Arzu Yorgancioglu
Journal:  Eur Respir J       Date:  2020-07-23       Impact factor: 16.671

6.  The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.

Authors:  Aida Fallahzadeh; Yeganeh Sharifnejad Tehrani; Ali Sheikhy; Seyyed-Hadi Ghamari; Esmaeil Mohammadi; Sahar Saeedi Moghaddam; Zahra Esfahani; Maryam Nasserinejad; Parnian Shobeiri; Mohammad-Mahdi Rashidi; Nazila Rezaei; Mahsa Heidari-Foroozan; Negar Rezaei; Bagher Larijani; Farshad Farzadfar
Journal:  Respir Res       Date:  2022-09-29

7.  Mortality due to noninfectious lower respiratory diseases: A spatiotemporal, cross-sectional study.

Authors:  Parastoo Amiri; Soheil Hashtarkhani; Ashraf Yazdizadeh; Leila Ahmadian
Journal:  Health Sci Rep       Date:  2022-10-07

8.  Obesity-Associated Metabolic Signatures Correlate to Clinical and Inflammatory Profiles of Asthma: A Pilot Study.

Authors:  Ying Liu; Jing Zheng; Hong Ping Zhang; Xin Zhang; Lei Wang; Lisa Wood; Gang Wang
Journal:  Allergy Asthma Immunol Res       Date:  2018-11       Impact factor: 5.764

9.  Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.

Authors:  Min Xie; Xiansheng Liu; Xiaopei Cao; Mingzhou Guo; Xiaochen Li
Journal:  Respir Res       Date:  2020-02-11

Review 10.  Patient's treatment burden related to care coordination in the field of respiratory diseases.

Authors:  Paola Pierucci; Carla Santomasi; Nicolino Ambrosino; Andrea Portacci; Fabrizio Diaferia; Kjeld Hansen; Mikaela Odemyr; Steve Jones; Giovanna E Carpagnano
Journal:  Breathe (Sheff)       Date:  2021-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.